IKZF1 and acute lymphoblastic leukemia: While the significance of these abnormalities is known in the indication of ALL, the method may be useful for analyses in other malignancies and in immunity, as the role of the IKZF1 deletions needs to be explored further and incorporated into treatment decisions.